SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-011500
Filing Date
2023-04-28
Accepted
2023-04-28 08:10:44
Documents
23

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pbyi20230303_def14a.htm   iXBRL DEF 14A 1150216
6 auerback01.jpg GRAPHIC 8362
7 boardtenure.jpg GRAPHIC 14754
8 compactuallypaidvsnetincome.jpg GRAPHIC 39446
9 compvsrev.jpg GRAPHIC 40544
10 compvtsr.jpg GRAPHIC 55837
11 i01.jpg GRAPHIC 29760
12 pblogo01.jpg GRAPHIC 11354
13 pc03.jpg GRAPHIC 139471
14 pc04.jpg GRAPHIC 122922
  Complete submission text file 0001437749-23-011500.txt   3060231

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20221231.xsd EX-101.SCH 8350
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20221231_def.xml EX-101.DEF 10813
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20221231_lab.xml EX-101.LAB 23150
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20221231_pre.xml EX-101.PRE 10781
17 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20230303_def14a_htm.xml XML 139336
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35703 | Film No.: 23860354
SIC: 2834 Pharmaceutical Preparations